M&A Deal Summary |
|
---|---|
Date | 2021-05-27 |
Target | Akorn - Consumer Health Business |
Sector | Life Science |
Buyer(s) | Prestige Consumer Healthcare |
Sellers(s) | Akorn |
Deal Type | Divestiture |
Deal Value | 230M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1996 |
Sector | Consumer Products |
Employees | 570 |
Revenue | 1.1B USD (2024) |
Prestige Consumer Healthcare markets and distributes brand name over-the-counter medicines and household cleaning products throughout the US, Canada, Australia, and other select international markets. Prestige Consumer was founded in 1996 and is based in Tarrytown, New York.
DEAL STATS | # |
---|---|
Overall | 14 of 14 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 6 of 6 |
State (Illinois) | 1 of 1 |
Country (United States) | 13 of 13 |
Year (2021) | 1 of 1 |
Size (of disclosed) | 3 of 8 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-07-02 |
Prestige Brands Holdings - Household Cleaning Business
Tarrytown, New York, United States Prestige Brands Holdings, Inc. - Household Cleaning Business includes Comet, Spic and Span, Cinch, Chore Boy and Chlorinol household product brands and related inventory. With the sale of these brands the Company’s portfolio will be comprised entirely of consumer healthcare brands. The divestiture enables the Company to further concentrate its brand-building efforts around its “invest for growth” consumer healthcare brand portfolio to help support long-term organic growth. |
Sell | $69M |
Category | Company |
---|---|
Founded | 1971 |
Sector | Life Science |
Employees | 1,972 |
Revenue | 1.1B USD (2016) |
Akorn, Inc. is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Akorn, Inc. was founded in 1971 and is based in Lake Forest, Illinois.
DEAL STATS | # |
---|---|
Overall | 3 of 4 |
Sector (Life Science) | 2 of 2 |
Type (Divestiture) | 2 of 3 |
State (Illinois) | 1 of 2 |
Country (United States) | 3 of 4 |
Year (2021) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-10-24 |
Aciex Therapeutics
Boston, Massachusetts, United States Aciex Therapeutics, Inc. is an ophthalmic pharmaceutical company centered on developing first in class products to treat ocular diseases. |
Sell | $120M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-03-09 |
Akorn - Ophthalmic Products
Lake Forest, Illinois, United States Akorn's Ophthalmic seven products include established glaucoma therapies Zioptan, Cosopt, Cosopt PF, and Betimol, along with Azasite, Akten, and the ocular surface repair agent AcellFX. |
Sell | - |